Cytosorbents CorporationCTSONASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+11.9%
5Y CAGR+0.5%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+11.9%/yr
vs +12.9%/yr prior
5Y CAGR
+0.5%/yr
Recent acceleration
Acceleration
-1.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1x
Modest growth
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$29.09M+15.8%
2024$25.13M+14.5%
2023$21.95M+5.9%
2022$20.73M-28.7%
2021$29.06M+2.3%
2020$28.40M+84.4%
2019$15.40M+20.7%
2018$12.76M+62.3%
2017$7.86M+84.9%
2016$4.25M-